Background technology
Raising and the dietary structure of people's living standard change, and cause the people who suffers from hypertension, high fat of blood and hyperglycaemia day by day to increase, and angiocardiopathies such as " three height " becomes the killer of human health.
Clinical medicine for reducing cholesterol has several classes at present: Statins is trimethyl glutaryl coenzyme A (HMG-CoA) reductase inhibitor, suppresses synzyme; The special class of shellfish is that to suppress triglycerides be main; The nicotinic acid class belongs to vitamin B complex; Cholic acid chelating agent; Cholesterol absorption inhibitor is of little use.More or less there are some bad reactions in this five classes medicine.
At present clinical have several classes for hypoglycemic medicine: Drugs Promoting Insulin Secretion is to promote insulin secretion and work, and commonly used have sulfonylureas, non-sulfonylureas and a biguanides; Alpha-glucosidase inhibitor delays starch, sucrose and maltose and be decomposed into glucose in small intestine, reduces postprandial blood sugar; Insulin sensitizer can improve the ability of utilizing insulin; Insulin and similar medicine thereof.These a few class medicines, to the ND of hyperglycaemia and are not suitable for all for diabetes.
The absorption of hyperglycaemia and high fat of blood and food has substantial connection, and has a big chunk crowd also not need to carry out drug therapy.Gu and by improving dietary structure, this type of disease can more effectively be alleviated or treat to the adjustment rule of life.
The present invention is comprised of daily bread, and apparent in view hypoglycemic lipid-lowering effect is arranged, and safe, is fit to have the patient of hyperglycaemia and high fat of blood as the diet replenishers.
By non-patent and the Searches of Patent Literature, search " a kind of biscuit with hypoglycemic, lipid-reducing function " of the patent No. 10999430.
Summary of the invention
The purpose of this invention is to provide a kind of composition with hypoglycemic lipid-lowering effect.
Soybean phytosterol:
Sterol refers to the organic matter take perhydrocyclopentanophenanthrene as skeleton, can be divided into animality sterol, plant sterols and bacterium property sterol.Animality take cholesterol as main; Vegetal sitosterol, stigmasterol and the campesterol etc. of being mainly; Bacterium property is mainly ergosterol.Human body is synthesizing phytosterol voluntarily, and absorption efficiency is not high yet, well below the absorptivity of cholesterol.This mainly is that the Phospholipids of human body etc. is more got close to cholesterol because the phytosterol dissolubility is poor.
The soybean phytosterol major part is demethlyate sterol, and wherein sitosterol, stigmasterol and campesterol account for more than 50%.Soybean phytosterol is the constituent of Various Tissues and cell, forms lipoprotein with protein bound, consists of the film of cell.
Relevant research data proves, phytosterol does not have obvious subacute toxicity and mutagenicity.
Physiological action:
1, soybean phytosterol has the effect that reduces serum cholesterol, reduces angiocardiopathy.
2, the soybean phytosterol security is very high, without subacute and mutagenicity effect.
Bitter buckwheat:
Bitter buckwheat is the polygonaceae plant hull buckwheat
FagopyrumtataricumSeed, be a kind of medicine-food two-purpose crop of uniqueness, originate in the ground such as China and India, China mainly is distributed in loess plateau high and cold mountain area and mountain region, plateau, river, Yunnan-Guizhou.The Liangshan of Sichuan Province area is the main place of production of bitter buckwheat.
Its property is sweet, cold, the effect of have heat-clearing, promote the production of body fluid, quenching the thirst.Modern clinical research shows, bitter buckwheat has certain prophylactic treatment effect to obesity, diabetes, high fat of blood etc.
Relevant research data proves, bitter buckwheat does not have obvious acute toxicity and mutagenesis.
Physiological action:
1, the linoleic acid that enriches in the bitter buckwheat, vitamin, phytosterol, rutin, trace elements of selenium etc. have the effect of reducing blood sugar and blood fat.
2, bitter buckwheat reduces the inhibitory action to central nervous system by suppressing the formation of serotonin, and plays the effect of antifatigue.
3, bitter buckwheat has weak estrogen-like action because containing flavone compound.
4, bitter buckwheat has obvious protective effect to the chemical damage mouse.
5, bitter buckwheat has the enhancing activities of antioxidant enzymes, the effect of anti peroxidation of lipid.
The specific embodiment:
The invention will be further described by the following examples.
Embodiment: a kind of composition for hypoglycemic norcholesterol (powdery)
The present embodiment is selected bitter buckwheat, and the mixing soya beans phytosterol is filled a prescription by following raw material and consumption thereof.
The bitter buckwheat 1000 of soybean phytosterol 0.1-50
The bitter buckwheat of above-mentioned raw materials is mixed with soybean phytosterol, and the rear drying that stirs shatters rear mistake 60 mesh sieves, makes powdery.Brew with boiling water and to drink.